Variability in bioburden testing presents a significant challenge in ensuring accurate microbial enumeration during biopharmaceutical manufacturing. This study provides a quantitative framework for ...
Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback